FDA approves breakthrough pancreatic cancer drug – an oncologist explains how daraxonrasib nearly doubles survival
Pancreatic cancer has been notoriously difficult to target and treat. wildpixel/iStock via Getty Images Plus For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For…